Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 181

1.

Validation of automated artificial intelligence segmentation of optical coherence tomography images.

Maloca PM, Lee AY, de Carvalho ER, Okada M, Fasler K, Leung I, Hörmann B, Kaiser P, Suter S, Hasler PW, Zarranz-Ventura J, Egan C, Heeren TFC, Balaskas K, Tufail A, Scholl HPN.

PLoS One. 2019 Aug 16;14(8):e0220063. doi: 10.1371/journal.pone.0220063. eCollection 2019.

2.

Influence of Postoperative Posture on Macular Slippage after Macula-Off Retinal Detachment: A Randomized Controlled Trial.

Schawkat M, Valmaggia C, Lang C, Scholl HPN, Harsum S, Guber I, Guber J.

Ophthalmol Ther. 2019 Aug 8. doi: 10.1007/s40123-019-0204-8. [Epub ahead of print]

PMID:
31396891
3.

[Unmet research and developmental needs in ophthalmology : A consensus-based road map of the European Vision Institute for 2019-2025].

Cursiefen C, Cordeiro F, Cunha-Vaz J, Wheeler-Schilling T, Scholl HPN; das EVI Steering Board.

Ophthalmologe. 2019 Sep;116(9):838-849. doi: 10.1007/s00347-019-00947-z. Review. German.

PMID:
31388757
4.

Unmet Needs in Ophthalmology: A European Vision Institute-Consensus Roadmap 2019-2025.

Cursiefen C, Cordeiro F, Cunha-Vaz J, Wheeler-Schilling T, Scholl HPN; EVI Steering Board.

Ophthalmic Res. 2019;62(3):123-133. doi: 10.1159/000501374. Epub 2019 Aug 5.

5.

Progression of Stargardt Disease as Determined by Fundus Autofluorescence Over a 12-Month Period: ProgStar Report No. 11.

Strauss RW, Kong X, Ho A, Jha A, West S, Ip M, Bernstein PS, Birch DG, Cideciyan AV, Michaelides M, Sahel JA, Sunness JS, Traboulsi EI, Zrenner E, Pitetta S, Jenkins D, Hariri AH, Sadda S, Scholl HPN; ProgStar Study Group.

JAMA Ophthalmol. 2019 Aug 1. doi: 10.1001/jamaophthalmol.2019.2885. [Epub ahead of print]

PMID:
31369039
6.

New Technologies for Outcome Measures in Retinal Disease: Review from the European Vision Institute Special Interest Focus Group.

Della Volpe-Waizel M, Traber GL, Maloca P, Zinkernagel M, Schmidt-Erfurth U, Rubin G, Roska B, Otto T, Weleber RG, Scholl HPN.

Ophthalmic Res. 2019 Jul 26:1-11. doi: 10.1159/000501887. [Epub ahead of print] Review.

7.

Targeting neuronal and glial cell types with synthetic promoter AAVs in mice, non-human primates and humans.

Jüttner J, Szabo A, Gross-Scherf B, Morikawa RK, Rompani SB, Hantz P, Szikra T, Esposti F, Cowan CS, Bharioke A, Patino-Alvarez CP, Keles Ö, Kusnyerik A, Azoulay T, Hartl D, Krebs AR, Schübeler D, Hajdu RI, Lukats A, Nemeth J, Nagy ZZ, Wu KC, Wu RH, Xiang L, Fang XL, Jin ZB, Goldblum D, Hasler PW, Scholl HPN, Krol J, Roska B.

Nat Neurosci. 2019 Aug;22(8):1345-1356. doi: 10.1038/s41593-019-0431-2. Epub 2019 Jul 8.

PMID:
31285614
8.

Reproducibility of Measurements of Retinal Structural Parameters Using Optical Coherence Tomography in Stargardt Disease.

Kong X, Ho A, Munoz B, West S, Strauss RW, Jha A, Ervin A, Buzas J, Singh M, Hu Z, Cheetham J, Ip M, Scholl HPN.

Transl Vis Sci Technol. 2019 Jun 21;8(3):46. doi: 10.1167/tvst.8.3.46. eCollection 2019 May.

9.

A Novel Mutation in the Choroideremia Gene in a Turkish Family.

Iftikhar M, Wolfson Y, Sodhi S, Usmani B, Scholl HPN, Shah SMA.

J Coll Physicians Surg Pak. 2019 Jul;29(7):677-679. doi: 10.29271/jcpsp.2019.07.677.

PMID:
31253224
10.

Statistical framework for validation without ground truth of choroidal thickness changes detection.

Ronchetti T, Jud C, Maloca PM, Orgül S, Giger AT, Meier C, Scholl HPN, Chun RKM, Liu Q, To CH, Považay B, Cattin PC.

PLoS One. 2019 Jun 28;14(6):e0218776. doi: 10.1371/journal.pone.0218776. eCollection 2019.

11.

A perfusion bioreactor-based 3D model of the subarachnoid space based on a meningeal tissue construct.

Neutzner A, Power L, Dürrenberger M, Scholl HPN, Meyer P, Killer HE, Wendt D, Kohler C.

Fluids Barriers CNS. 2019 Jun 13;16(1):17. doi: 10.1186/s12987-019-0137-6.

12.

Progression of Retinitis Pigmentosa as Measured on Microperimetry: The PREP-1 Study.

Iftikhar M, Kherani S, Kaur R, Lemus M, Nefalar A, Usmani B, Junaid N, Campochiaro PA, Scholl HPN, Shah SM.

Ophthalmol Retina. 2018 May;2(5):502-507. doi: 10.1016/j.oret.2017.09.008. Epub 2017 Nov 9.

PMID:
31047333
13.

How to Prevent Retinal Shift after Rhegmatogenous Retinal Detachment Repair: A Prospective, Randomized Study.

Guber J, Schawkat M, Lang C, Scholl HPN, Valmaggia C.

Ophthalmol Retina. 2019 May;3(5):417-421. doi: 10.1016/j.oret.2019.01.010. Epub 2019 Jan 21.

PMID:
31044733
14.

Comparative study of endolaser versus cryocoagulation in vitrectomy for rhegmatogenous retinal detachment.

Bentivoglio M, Valmaggia C, Scholl HPN, Guber J.

BMC Ophthalmol. 2019 Apr 25;19(1):96. doi: 10.1186/s12886-019-1099-9.

15.

A Workshop on Measuring the Progression of Atrophy Secondary to Stargardt Disease in the ProgStar Studies: Findings and Lessons Learned.

Ervin AM, Strauss RW, Ahmed MI, Birch D, Cheetham J, Ferris FL 3rd, Ip MS, Jaffe GJ, Maguire MG, Schönbach EM, Sadda SR, West SK, Scholl HPN; ProgStar Study Group.

Transl Vis Sci Technol. 2019 Apr 12;8(2):16. doi: 10.1167/tvst.8.2.16. eCollection 2019 Apr.

16.

Outcomes after Epiretinal Membrane Surgery with or Without Internal Limiting Membrane Peeling.

Guber J, Pereni I, Scholl HPN, Guber I, Haynes RJ.

Ophthalmol Ther. 2019 Jun;8(2):297-303. doi: 10.1007/s40123-019-0185-7. Epub 2019 Apr 19.

17.

[Acute Juvenile Ophthalmoplegia (Miller Fisher Syndrome): an Interesting Case].

Zuche H, Della Volpe Waizel M, Gatzioufas Z, Vastardis I, Scholl HP, Kozeis N.

Klin Monbl Augenheilkd. 2019 Apr;236(4):469-471. doi: 10.1055/a-0832-1815. Epub 2019 Apr 18. German. No abstract available.

PMID:
30999339
18.

Successful Big Bubble-Assisted Deep Anterior Lamellar Keratoplasty in a Patient with Intracorneal Ring Segments and Previous Corneal Collagen Cross-Linking for Keratoconus.

Della Volpe Waizel M, Elalfy M, Thabit A, Hamada S, Pruente C, Scholl HPN, Gatzioufas Z.

Klin Monbl Augenheilkd. 2019 Apr;236(4):379-381. doi: 10.1055/a-0859-6849. Epub 2019 Apr 18. No abstract available.

PMID:
30999334
19.

[Long-term Follow-up After Cryocoagulation in Preterm Newborns from Northern Greece with Retinopathy of Prematurity: Three Year Results].

Della Volpe Waizel M, Gatzioufas Z, Iraklis V, Soubasi V, Drossou-Agakidou V, Pruente C, Scholl HPN, Kozeis N.

Klin Monbl Augenheilkd. 2019 Apr;236(4):542-546. doi: 10.1055/a-0880-5168. Epub 2019 Apr 18. German.

PMID:
30999332
20.

Feasibility of support vector machine learning in age-related macular degeneration using small sample yielding sparse optical coherence tomography data.

Quellec G, Kowal J, Hasler PW, Scholl HPN, Zweifel S, Konstantinos B, de Carvalho JER, Heeren T, Egan C, Tufail A, Maloca PM.

Acta Ophthalmol. 2019 Aug;97(5):e719-e728. doi: 10.1111/aos.14055. Epub 2019 Mar 6.

PMID:
30839157
21.

Classification of disease severity in retinitis pigmentosa.

Iftikhar M, Lemus M, Usmani B, Campochiaro PA, Sahel JA, Scholl HPN, Shah SMA.

Br J Ophthalmol. 2019 Jan 31. pii: bjophthalmol-2018-313669. doi: 10.1136/bjophthalmol-2018-313669. [Epub ahead of print]

PMID:
30705041
22.

Ocular Mucous Membrane Pemphigoid: Current State of Pathophysiology, Diagnostics and Treatment.

Georgoudis P, Sabatino F, Szentmary N, Palioura S, Fodor E, Hamada S, Scholl HPN, Gatzioufas Z.

Ophthalmol Ther. 2019 Mar;8(1):5-17. doi: 10.1007/s40123-019-0164-z. Epub 2019 Jan 29. Review.

23.

Ophthalmic Research: Striving for Excellence in Serving the Community.

Scholl HPN.

Ophthalmic Res. 2019;61(1):1-2. doi: 10.1159/000496216. Epub 2019 Jan 9. No abstract available.

24.

An Unusual Case of "Red Eye".

Janeschitz-Kriegl L, Meyer P, Scholl HP, Della Volpe Waizel M.

Klin Monbl Augenheilkd. 2019 Apr;236(4):377-378. doi: 10.1055/a-0795-3136. Epub 2019 Jan 7. No abstract available.

PMID:
30616282
25.

Impact of segmentation density on spectral domain optical coherence tomography assessment in Stargardt disease.

Velaga SB, Nittala MG, Jenkins D, Melendez J, Ho A, Strauss RW, Scholl HP, Sadda SR.

Graefes Arch Clin Exp Ophthalmol. 2019 Mar;257(3):549-556. doi: 10.1007/s00417-018-04229-3. Epub 2019 Jan 6.

PMID:
30613916
26.

Progression of retinitis pigmentosa on multimodal imaging: The PREP-1 study.

Iftikhar M, Usmani B, Sanyal A, Kherani S, Sodhi S, Bagheri S, Schönbach EM, Junaid N, Scholl HPN, Shah SMA.

Clin Exp Ophthalmol. 2019 Jul;47(5):605-613. doi: 10.1111/ceo.13458. Epub 2019 Jan 2.

PMID:
30552737
27.

[Long-term Outcome after Autologous Free Internal Limiting Membrane Flap for the Treatment of Refractory Macular Holes].

Guber J, Vieregge M, Scholl HPN, Valmaggia C.

Klin Monbl Augenheilkd. 2019 Aug;236(8):1012-1015. doi: 10.1055/a-0651-0687. Epub 2018 Oct 16. German.

PMID:
30326539
28.

Surgical Outcome after Lamellar Macular Hole Associated with Epiretinal Membrane.

Guber J, Scholl HPN, Valmaggia C.

Ophthalmologica. 2019;241(1):56-60. doi: 10.1159/000493349. Epub 2018 Oct 11.

PMID:
30308511
29.

MICROPERIMETRY AS A SCREENING TEST FOR HYDROXYCHLOROQUINE RETINOPATHY: The Hard-Risk-1 Study.

Iftikhar M, Kaur R, Nefalar A, Usmani B, Kherani S, Rashid I, Schönbach E, Petri M, Scholl HPN, Shah SM.

Retina. 2019 Mar;39(3):485-491. doi: 10.1097/IAE.0000000000002313.

PMID:
30234854
30.

Interdevice variability of central corneal thickness measurement.

Maloca PM, Studer HP, Ambrósio R Jr, Goldblum D, Rothenbuehler S, Barthelmes D, Zweifel S, Scholl HPN, Balaskas K, Tufail A, Hasler PW.

PLoS One. 2018 Sep 13;13(9):e0203884. doi: 10.1371/journal.pone.0203884. eCollection 2018.

31.

The Progression of the Stargardt Disease Type 4 (ProgStar-4) Study: Design and Baseline Characteristics (ProgStar-4 Report No. 1).

Strauss RW, Muñoz B, Ahmed MI, Bittencourt M, Schönbach EM, Michaelides M, Birch D, Zrenner E, Ervin AM, Charbel Issa P, Kong J, Wolfson Y, Shah M, Bagheri S, West S, Scholl HPN; for the ProgStar-4 Study Group.

Ophthalmic Res. 2018;60(3):185-194. doi: 10.1159/000491791. Epub 2018 Aug 15.

PMID:
30110705
32.

Safety and Feasibility of a Novel Sparse Optical Coherence Tomography Device for Patient-Delivered Retina Home Monitoring.

Maloca P, Hasler PW, Barthelmes D, Arnold P, Matthias M, Scholl HPN, Gerding H, Garweg J, Heeren T, Balaskas K, de Carvalho JER, Egan C, Tufail A, Zweifel SA.

Transl Vis Sci Technol. 2018 Jul 24;7(4):8. doi: 10.1167/tvst.7.4.8. eCollection 2018 Jul.

33.

High-Performance Virtual Reality Volume Rendering of Original Optical Coherence Tomography Point-Cloud Data Enhanced With Real-Time Ray Casting.

Maloca PM, de Carvalho JER, Heeren T, Hasler PW, Mushtaq F, Mon-Williams M, Scholl HPN, Balaskas K, Egan C, Tufail A, Witthauer L, Cattin PC.

Transl Vis Sci Technol. 2018 Jul 9;7(4):2. doi: 10.1167/tvst.7.4.2. eCollection 2018 Jul.

34.

Scotopic Microperimetric Assessment of Rod Function in Stargardt Disease (SMART) Study: Design and Baseline Characteristics (Report No. 1).

Strauss RW, Kong X, Bittencourt MG, Ho A, Jha A, Schönbach EM, Ahmed MI, Muñoz B, Ervin AM, Michaelides M, Birch DG, Sahel JA, Sunness JS, Zrenner E, Bagheri S, Ip M, Sadda S, West S, Scholl HPN; for the SMART Study Group.

Ophthalmic Res. 2019;61(1):36-43. doi: 10.1159/000488711. Epub 2018 Jun 25.

PMID:
29940588
35.

Detailed genetic characteristics of an international large cohort of patients with Stargardt disease: ProgStar study report 8.

Fujinami K, Strauss RW, Chiang JP, Audo IS, Bernstein PS, Birch DG, Bomotti SM, Cideciyan AV, Ervin AM, Marino MJ, Sahel JA, Mohand-Said S, Sunness JS, Traboulsi EI, West S, Wojciechowski R, Zrenner E, Michaelides M, Scholl HPN; ProgStar Study Group; ProgStar Study Group.

Br J Ophthalmol. 2019 Mar;103(3):390-397. doi: 10.1136/bjophthalmol-2018-312064. Epub 2018 Jun 20.

36.

Visual Acuity Change Over 24 Months and Its Association With Foveal Phenotype and Genotype in Individuals With Stargardt Disease: ProgStar Study Report No. 10.

Kong X, Fujinami K, Strauss RW, Munoz B, West SK, Cideciyan AV, Michaelides M, Ahmed M, Ervin AM, Schönbach E, Cheetham JK, Scholl HPN; ProgStar Study Group.

JAMA Ophthalmol. 2018 Aug 1;136(8):920-928. doi: 10.1001/jamaophthalmol.2018.2198.

37.

Longitudinal Changes of Fixation Location and Stability Within 12 Months in Stargardt Disease: ProgStar Report No. 12.

Schönbach EM, Strauss RW, Kong X, Muñoz B, Ibrahim MA, Sunness JS, Birch DG, Hahn GA, Nasser F, Zrenner E, Sadda SR, West SK, Scholl HPN; ProgStar Study Group.

Am J Ophthalmol. 2018 Sep;193:54-61. doi: 10.1016/j.ajo.2018.06.003. Epub 2018 Jun 8.

PMID:
29890160
38.

Microstructural retinal regeneration after internal limiting membrane flap surgery for repair of large macular holes: a 1-year follow-up study.

Vieregge M, Valmaggia C, Scholl HPN, Guber J.

Int Ophthalmol. 2019 Jun;39(6):1277-1282. doi: 10.1007/s10792-018-0941-z. Epub 2018 May 9.

PMID:
29744761
39.

Enhanced resolution and speckle-free three-dimensional printing of macular optical coherence tomography angiography.

Maloca PM, Spaide RF, Rothenbuehler S, Scholl HPN, Heeren T, Ramos de Carvalho JE, Okada M, Hasler PW, Egan C, Tufail A.

Acta Ophthalmol. 2019 Mar;97(2):e317-e319. doi: 10.1111/aos.13567. Epub 2017 Nov 13. No abstract available.

PMID:
29131515
40.

Progression of Stargardt Disease as Determined by Fundus Autofluorescence in the Retrospective Progression of Stargardt Disease Study (ProgStar Report No. 9).

Strauss RW, Muñoz B, Ho A, Jha A, Michaelides M, Cideciyan AV, Audo I, Birch DG, Hariri AH, Nittala MG, Sadda S, West S, Scholl HPN; ProgStar Study Group.

JAMA Ophthalmol. 2017 Nov 1;135(11):1232-1241. doi: 10.1001/jamaophthalmol.2017.4152.

41.

Metrics and Acquisition Modes for Fixation Stability as a Visual Function Biomarker.

Schönbach EM, Ibrahim MA, Kong X, Strauss RW, Muñoz B, Birch DG, Sunness JS, West SK, Scholl HPN.

Invest Ophthalmol Vis Sci. 2017 May 1;58(6):BIO268-BIO276. doi: 10.1167/iovs.17-21710.

42.

Towards Treatment of Stargardt Disease: Workshop Organized and Sponsored by the Foundation Fighting Blindness.

Sears AE, Bernstein PS, Cideciyan AV, Hoyng C, Charbel Issa P, Palczewski K, Rosenfeld PJ, Sadda S, Schraermeyer U, Sparrow JR, Washington I, Scholl HPN.

Transl Vis Sci Technol. 2017 Sep 14;6(5):6. doi: 10.1167/tvst.6.5.6. eCollection 2017 Sep. Review.

43.

A NOVEL LARGE HOMOZYGOUS DELETION IN THE CELLULAR RETINALDEHYDE-BINDING PROTEIN GENE (RLBP1) IN A PATIENT WITH RETINITIS PUNCTATA ALBESCENS.

Bagheri S, Pantrangi M, Sodhi SK, Bagheri S, Oellers P, Scholl HPN.

Retin Cases Brief Rep. 2017 Aug 18. doi: 10.1097/ICB.0000000000000628. [Epub ahead of print]

PMID:
28827498
44.

7-Hexagon Multifocal Electroretinography for an Objective Functional Assessment of the Macula in 14 Seconds.

Schönbach EM, Chaikitmongkol V, Annam R, McDonnell EC, Wolfson Y, Fletcher E, Scholl HPN.

Ophthalmic Res. 2017;58(2):117-124. doi: 10.1159/000475996. Epub 2017 Jun 23.

PMID:
28641302
45.

Specific Alleles of CLN7/MFSD8, a Protein That Localizes to Photoreceptor Synaptic Terminals, Cause a Spectrum of Nonsyndromic Retinal Dystrophy.

Khan KN, El-Asrag ME, Ku CA, Holder GE, McKibbin M, Arno G, Poulter JA, Carss K, Bommireddy T, Bagheri S, Bakall B, Scholl HP, Raymond FL, Toomes C, Inglehearn CF, Pennesi ME, Moore AT, Michaelides M, Webster AR, Ali M; for NIHR BioResource-Rare Diseases and UK Inherited Retinal Disease Consortium.

Invest Ophthalmol Vis Sci. 2017 Jun 1;58(7):2906-2914. doi: 10.1167/iovs.16-20608.

46.

Visual Acuity Change over 12 Months in the Prospective Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: ProgStar Report Number 6.

Kong X, Strauss RW, Cideciyan AV, Michaelides M, Sahel JA, Munoz B, Ahmed M, Ervin AM, West SK, Cheetham JK, Scholl HPN; ProgStar Study Group.

Ophthalmology. 2017 Nov;124(11):1640-1651. doi: 10.1016/j.ophtha.2017.04.026. Epub 2017 May 23.

PMID:
28549516
47.

Incidence of Atrophic Lesions in Stargardt Disease in the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: Report No. 5.

Strauss RW, Muñoz B, Ho A, Jha A, Michaelides M, Mohand-Said S, Cideciyan AV, Birch D, Hariri AH, Nittala MG, Sadda S, Scholl HPN; ProgStar Study Group.

JAMA Ophthalmol. 2017 Jul 1;135(7):687-695. doi: 10.1001/jamaophthalmol.2017.1121.

48.

Macular Sensitivity Measured With Microperimetry in Stargardt Disease in the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: Report No. 7.

Schönbach EM, Wolfson Y, Strauss RW, Ibrahim MA, Kong X, Muñoz B, Birch DG, Cideciyan AV, Hahn GA, Nittala M, Sunness JS, Sadda SR, West SK, Scholl HPN; ProgStar Study Group.

JAMA Ophthalmol. 2017 Jul 1;135(7):696-703. doi: 10.1001/jamaophthalmol.2017.1162.

49.

THREE-DIMENSIONAL ANALYSIS OF SUBMACULAR PERFORATING SCLERAL VESSELS BY ENHANCED DEPTH IMAGING OPTICAL COHERENCE TOMOGRAPHY.

Rothenbuehler SP, Maloca P, Scholl HPN, Gyger C, Schoetzau A, Kuske L, Mosimann N, Zweifel SA, Barthelmes D, Tufail A, Hasler PW.

Retina. 2018 Jun;38(6):1231-1237. doi: 10.1097/IAE.0000000000001686.

50.

Progression of Visual Acuity and Fundus Autofluorescence in Recent-Onset Stargardt Disease: ProgStar Study Report #4.

Kong X, West SK, Strauss RW, Munoz B, Cideciyan AV, Michaelides M, Ho A, Ahmed M, Schönbach EM, Cheetham JK, Ervin AM, Scholl HPN; ProgStar study group.

Ophthalmol Retina. 2017 Nov - Dec;1(6):514-523. doi: 10.1016/j.oret.2017.02.008. Epub 2017 Apr 28.

PMID:
31047445

Supplemental Content

Loading ...
Support Center